The present study was to evaluate the circulating and hepatic resistin expression in patients with biopsy-proven NASH and those with simple steatosis, and to assess the associations of resistin expression with metabolic profiles and inflammation in human liver. This evidence concerns the gene RETN and metabolic dysfunction-associated steatohepatitis.